AGP Picks
View all

French Guiana Wellness Network
Provided by AGP

French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 6, 2026

MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update
May 6, 2026

MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update

Indeterminate GlobeNewswire
NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors
May 6, 2026

NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors

Indeterminate GlobeNewswire
BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle
May 6, 2026

BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle

Indeterminate GlobeNewswire
Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors
May 6, 2026

Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors

Indeterminate GlobeNewswire
[Latest] Pharmaceutical Suppositories Market Size to Hit USD 13.4 Bn at a CAGR of 3.5% by 2034 - Report by Zion Market Research
May 6, 2026

[Latest] Pharmaceutical Suppositories Market Size to Hit USD 13.4 Bn at a CAGR of 3.5% by 2034 - Report by Zion Market Research

Indeterminate GlobeNewswire
Where Executives Are Doubling Down on Their Companies’ Fortunes
May 6, 2026

Where Executives Are Doubling Down on Their Companies’ Fortunes

Indeterminate GlobeNewswire
Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
May 6, 2026

Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models

Indeterminate GlobeNewswire
Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101
May 6, 2026

Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101

Indeterminate GlobeNewswire
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
May 6, 2026

Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

Indeterminate GlobeNewswire
Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th
May 6, 2026

Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th

Indeterminate GlobeNewswire
Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update
May 6, 2026

Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update

Indeterminate GlobeNewswire
Cristcot Appoints Rayna Herman as President of its Hydrocortisone Acetate Commercial Division
May 6, 2026

Cristcot Appoints Rayna Herman as President of its Hydrocortisone Acetate Commercial Division

Indeterminate GlobeNewswire
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
May 6, 2026

Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease

Indeterminate GlobeNewswire
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions
May 6, 2026

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

Indeterminate GlobeNewswire
CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference
May 6, 2026

CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference

Indeterminate GlobeNewswire
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
May 6, 2026

InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares

Indeterminate GlobeNewswire
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
May 6, 2026

InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases

Indeterminate GlobeNewswire
SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041
May 6, 2026

SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041

Indeterminate GlobeNewswire
Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement
May 6, 2026

Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement

Indeterminate GlobeNewswire
Aktis Oncology to Present at the BofA Securities Health Care Conference
May 6, 2026

Aktis Oncology to Present at the BofA Securities Health Care Conference

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

French Guiana Wellness Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.